View Older Stories View More Recent Stories

May 7, 2025 05:24AM AbbVie (ABBV) call put ratio 1.3 calls to 1 put on active volume of 34K contracts
May 3, 2025 10:00AM What is the impact of U.S. tariffs on biopharma sector?
Apr 29, 2025 07:40AM Abbvie (ABBV) PT Raised to $216 at Guggenheim
Apr 29, 2025 07:30AM AbbVie (ABBV) Reports RINVOQ Received FDA Approval for Giant Cell Arteritis (GCA)
Apr 28, 2025 11:34AM HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
Apr 28, 2025 06:40AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV)
Apr 25, 2025 07:57AM AbbVie (ABBV) EPS Beats Consensus, Updates Guidance
Apr 25, 2025 04:00AM AbbVie set to report Q1 results: Focus on Skyrizi, Rinvoq and Part D impact
Apr 24, 2025 11:36AM AbbVie (ABBV) call put ratio 1.5 calls to 1 put with a focus on May 182.50
Apr 24, 2025 08:30AM AbbVie (ABBV) Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE
Apr 24, 2025 05:18AM AbbVie (ABBV) call put ratio 1.7 calls to 1 put into quarter results
Apr 22, 2025 08:05AM Bernstein SocGen Group Reiterates Market Perform Rating on Abbvie (ABBV)
Apr 22, 2025 07:18AM Cantor Fitzgerald Starts Abbvie (ABBV) at Overweight
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 8, 2025 05:06AM Goldman Sachs Assumes Abbvie (ABBV) at Neutral
Apr 3, 2025 04:15PM AbbVie (ABBV) issues updated guidance
Apr 1, 2025 09:33AM Bernstein Assesses U.S. Biopharma Stocks Amid Tariff Risks
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 24, 2025 08:38AM Genmab (GMAB) to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. (ABBV)
Mar 17, 2025 08:54AM Erste Group Upgrades Abbvie (ABBV) to Buy (Friday pre-market)
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?
Mar 12, 2025 05:20AM Abbvie (ABBV) PT Raised to $195 at Berenberg
Mar 4, 2025 10:16AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV) as They Enter Obesity
Mar 4, 2025 10:16AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV) as They Enter Obesity
Mar 4, 2025 07:07AM Bernstein Reiterates Market Perform on Abbvie (ABBV) Following Gubra Agreement
Mar 3, 2025 02:34PM Abbvie (ABBV) PT Raised to $223 at BofA Securities
Feb 14, 2025 08:50AM AbbVie (ABBV) appoints CEO as Chairman of board
Feb 14, 2025 07:35AM AbbVie (ABBV) Appoints CEO Robert A. Michael as Chairman of the Board of Directors
Feb 13, 2025 11:58AM AbbVie (ABBV) Declares $1.64 Quarterly Dividend; 3.4% Yield
Feb 12, 2025 08:44AM AbbVie's Allergan Aesthetics set to launch three new training centers in U.S.
Feb 12, 2025 07:31AM AbbVie (ABBV) and Xilio Therapeutics (XLO) Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Feb 7, 2025 01:28PM AbbVie (ABBV) Announces FDA Approval of EMBLAVEO
Feb 3, 2025 08:28AM Abbvie (ABBV) PT Raised to $215 at BMO Capital as 'Guidance Raise Gives More Confidence'
Feb 3, 2025 07:11AM Abbvie (ABBV) PT Raised to $214 at Guggenheim
Feb 3, 2025 06:21AM Abbvie (ABBV) PT Raised to $210 at Leerink Partners
Feb 3, 2025 05:41AM Abbvie (ABBV) PT Raised to $220 at Raymond James
Feb 3, 2025 05:17AM Abbvie (ABBV) PT Raised to $212 at Goldman Sachs
Jan 31, 2025 07:37AM AbbVie (ABBV) Tops Q4 EPS by 10c, Offers Guidance
Jan 30, 2025 11:03AM AbbVie (ABBV) call put ratio 1.8 calls to 1 put into quarter results
Jan 30, 2025 04:50AM AbbVie (ABBV) call put ratio 1.1 calls to 1 put into quarter results
Jan 28, 2025 05:27AM Raymond James Reiterates Outperform Rating on Abbvie (ABBV)
Jan 27, 2025 07:46AM Abbvie (ABBV) PT Raised to $227 as Piper Sandler 'Likes the Chances for Upside'
Jan 27, 2025 05:51AM Abbvie (ABBV) PT Raised to $208 at Goldman Sachs
Jan 23, 2025 09:17AM AbbVie (ABBV) Completes Acquisition of Nimble Therapeutics
Jan 23, 2025 09:00AM AbbVie (ABBV) and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
Jan 17, 2025 07:11AM Abbvie (ABBV) PT Lowered to $212 at Guggenheim
Jan 16, 2025 11:50AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV) as I&I Portfolio Sees New Avenues for Growth in 2025
Jan 15, 2025 11:26AM AbbVie (ABBV) Falls 2% with Presentation at JPMorgan Ongoing
View More Recent Stories View Older Stories